(Q40601230)

21 September 2017

title

Msh2 deficiency does not contribute to cisplatin resistance in mouse embryonic stem cells (English)

1 reference

21 September 2017

Nanna Claij

1

1 reference

21 September 2017

Hein te Riele

series ordinal

2

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

23

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

260-266

1 reference

Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

DNA damage invokes mismatch repair-dependent cyclin D1 attenuation and retinoblastoma signaling pathways to inhibit CDK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

A hPMS2 mutant cell line is defective in strand-specific mismatch repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

A change in microsatellite instability caused by cisplatin-based chemotherapy of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

7 January 2021

Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

7 January 2021

Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

7 January 2021

Dependence on RAD52 and RAD1 for anticancer drug resistance mediated by inactivation of mismatch repair genes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

7 January 2021

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

7 January 2021

Mechanisms of resistance to cisplatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

7 January 2021

DNA mismatch repair and acquired cisplatin resistance in E. coli and human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

7 January 2021

The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

7 January 2021

Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

7 January 2021

The ability to engage enterocyte apoptosis does not predict long-term crypt survival in p53 and Msh2 deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

7 January 2021

Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

7 January 2021

A role for mismatch repair in control of DNA ploidy following DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

7 January 2021

Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

7 January 2021

Efficient production of Cre-mediated site-directed recombinants through the utilization of the puromycin resistance gene, pac: a transient gene-integration marker for ES cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

7 January 2021

Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

7 January 2021

DNA replication arrest and tolerance to DNA methylation damage.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207015

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207015

1 reference

Dimensions Publication ID

21 September 2017

1027570255

0 references

1 reference